Cite
HARVARD Citation
Mantzaris, G. et al. (n.d.). DOP60 Simplified rules to identify bio-naïve patients with Crohn's Disease with higher likelihood of clinical remission when initiating vedolizumab versus anti-TNFα therapies: Analysis of EVOLVE study data. Journal of Crohn's and colitis. pp. S095-S096. [Online].